XENVERY Trademark

Trademark Overview

On Tuesday, June 1, 2010, a trademark application was filed for XENVERY with the United States Patent and Trademark Office. The USPTO has given the XENVERY trademark a serial number of 85051681. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 10, 2014. This trademark is owned by Glaxo Group Limited. The XENVERY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines
xenvery

General Information

Serial Number85051681
Word MarkXENVERY
Filing DateTuesday, June 1, 2010
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 10, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 7, 2010

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines
Pseudo MarkXEN VERY

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, June 4, 2010
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Monday, March 10, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, March 10, 2014ABANDONMENT - NO USE STATEMENT FILED
Tuesday, July 30, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 29, 2013EXTENSION 5 GRANTED
Friday, July 26, 2013EXTENSION 5 FILED
Friday, July 26, 2013TEAS EXTENSION RECEIVED
Monday, March 25, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 25, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, March 15, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 15, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, January 24, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 23, 2013EXTENSION 4 GRANTED
Monday, January 21, 2013EXTENSION 4 FILED
Monday, January 21, 2013TEAS EXTENSION RECEIVED
Friday, July 27, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 26, 2012EXTENSION 3 GRANTED
Wednesday, July 25, 2012EXTENSION 3 FILED
Wednesday, July 25, 2012TEAS EXTENSION RECEIVED
Thursday, February 16, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 15, 2012EXTENSION 2 GRANTED
Thursday, January 19, 2012EXTENSION 2 FILED
Wednesday, February 15, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, January 19, 2012TEAS EXTENSION RECEIVED
Thursday, July 21, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 19, 2011EXTENSION 1 GRANTED
Tuesday, July 19, 2011EXTENSION 1 FILED
Tuesday, July 19, 2011TEAS EXTENSION RECEIVED
Tuesday, February 1, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 7, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 7, 2010PUBLISHED FOR OPPOSITION
Wednesday, November 3, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, October 26, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, October 22, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 22, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, October 22, 2010APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, October 22, 2010ASSIGNED TO LIE
Monday, October 11, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 12, 2010TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 14, 2010NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, September 14, 2010NON-FINAL ACTION E-MAILED
Tuesday, September 14, 2010NON-FINAL ACTION WRITTEN
Monday, September 13, 2010ASSIGNED TO EXAMINER
Saturday, June 5, 2010NOTICE OF PSEUDO MARK MAILED
Friday, June 4, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, June 4, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

xenvery pharmaceutical treatment substances disorders preparations diseases hormonal neurological gastrointestinal ophthalmic